(0.29%) 5 121.50 points
(0.02%) 38 733 points
(0.74%) 17 737 points
(-0.46%) $82.98
(-1.43%) $1.786
(-0.63%) $2 327.30
(-0.76%) $27.16
(-0.36%) $919.50
(0.13%) $0.935
(0.70%) $10.98
(0.11%) $0.804
(-0.79%) $92.46
Live Chart Being Loaded With Signals
Annovis Bio, Inc., a clinical stage drug platform company, develops drugs to treat neurodegeneration. The company's lead compound is Buntanetap, an orally administered drug, which has completed Phase 2a clinical trials for the treatment of Alzheimer's disease (AD) and Parkinson's disease, as well as is in clinical trials for Alzheimer's disease in Down Syndrome and other chronic neurodegenerative disorders...
Stats | |
---|---|
Today's Volume | 226 191 |
Average Volume | 241 812 |
Market Cap | 130.81M |
EPS | $0 ( 2024-04-01 ) |
Next earnings date | ( $-0.870 ) 2024-05-09 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -1.910 |
ATR14 | $0.0420 (0.35%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2023-11-20 | White Mark K. | Buy | 1 990 | Common Stock |
2023-11-20 | Mccarthy Reid | Buy | 0 | Common Stock |
2023-11-20 | Hoffman Michael B | Buy | 163 880 | Common Stock |
2023-11-20 | Maccecchini Maria-luisa | Buy | 40 970 | Common Stock |
2023-11-20 | Hagopian Henry Iii | Buy | 820 | Common Stock |
INSIDER POWER |
---|
89.97 |
Last 98 transactions |
Buy: 4 567 241 | Sell: 3 252 094 |
Volume Correlation
Annovis Bio Inc Correlation
10 Most Positive Correlations |
---|
10 Most Negative Correlations |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Annovis Bio Inc Correlation - Currency/Commodity
Annovis Bio Inc Financials
Annual | 2023 |
Revenue: | $0 |
Gross Profit: | $0 (0.00 %) |
EPS: | $-6.23 |
Q4 | 2023 |
Revenue: | $0 |
Gross Profit: | $0 (0.00 %) |
EPS: | $-2.33 |
Q3 | 2023 |
Revenue: | $0 |
Gross Profit: | $0 (0.00 %) |
EPS: | $-1.630 |
Q2 | 2023 |
Revenue: | $0 |
Gross Profit: | $0 (0.00 %) |
EPS: | $-1.070 |
Financial Reports:
No articles found.
Annovis Bio Inc
Annovis Bio, Inc., a clinical stage drug platform company, develops drugs to treat neurodegeneration. The company's lead compound is Buntanetap, an orally administered drug, which has completed Phase 2a clinical trials for the treatment of Alzheimer's disease (AD) and Parkinson's disease, as well as is in clinical trials for Alzheimer's disease in Down Syndrome and other chronic neurodegenerative disorders. It is also developing ANVS405 for protecting the traumatic brain injury and stroke; and ANVS301, which is in Phase I clinical trials to increase cognitive capability in later stages of AD and dementia. The company was incorporated in 2008 and is based in Berwyn, Pennsylvania.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators